Aragen Life Sciences
Aragen Life Sciences is a prominent discovery research and development organization in Asia, providing a comprehensive range of services across the R&D and manufacturing value chain. The company specializes in drug discovery, clinical development, contract manufacturing, formulation, and informatics, catering to the needs of healthcare institutions and other sectors. With over a decade of experience in delivering innovative drug discovery and development services, Aragen is equipped with a team of skilled scientists and advanced technologies that enable them to achieve exceptional results for their clients. The organization employs approximately 2,400 professionals and serves a diverse global customer base, including prominent players in pharmaceuticals, agrochemicals, electronics, biotechnology, and academia. Aragen Life Sciences is recognized for its commitment to quality, speed, and affordability, consistently meeting and exceeding customer expectations in their research endeavors.
Top Stages
3 past transactions
Intox
Acquisition in 2021
Intox is a pre-clinical contract research organization that provides a broad spectrum of non-clinical in-vivo and in-vitro research services. The company serves various industries, including pharmaceuticals, biopharmaceuticals, plant protection, nutraceuticals, and medical devices. Intox conducts comprehensive safety assessment studies, such as mammalian toxicity tests (acute, sub-chronic, chronic, and reproductive), in-vitro toxicity, mutagenicity, and environmental toxicity studies. These services support clients' product development and registration needs by ensuring rigorous research and testing standards are met.
Vanta Bioscience
Acquisition in 2014
Vanta Bioscience Limited is a preclinical contract research organization based in Secunderabad, India, with research laboratories in Chennai and additional offices in Brussels and West Des Moines. The company specializes in providing comprehensive non-clinical safety assessment services to a diverse clientele across various sectors, including pharmaceuticals, biotechnology, medical devices, cosmetics, agri-foods, nutritional supplements, and chemicals. Vanta Bioscience offers a range of services, including preclinical safety assessments, toxicology studies, biocompatibility testing, and environmental studies, along with risk assessments for pharmaceutical ingredients and exposure limits for manufacturers. Established in 2016, the company is also involved in research and development activities focused on drug discovery, biological products, vaccines, gene therapies, and diagnostics.
Aragen Bioscience
Acquisition in 2014
Aragen Bioscience, Inc. is a preclinical contract research and development organization based in Morgan Hill, California. Founded in 2006, the company specializes in providing a comprehensive range of services for the pharmaceutical and biotechnology sectors. Its expertise includes recombinant cell line and hybridoma development, cell culture, protein purification, and the creation of primary and immortalized cell-based assays. Aragen also offers in vivo models of human disease and custom immunological services. The company’s capabilities extend to molecular biology, process development, protein chemistry, and hybridoma development, enabling the production of monoclonal antibodies and various therapeutic proteins. Additionally, Aragen conducts pharmacokinetic studies, pharmacology assessments, and functional analyses across multiple disease models. With a focus on supporting drug discovery and development, Aragen Bioscience plays a crucial role in advancing biomedical research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.